Poor performance in the Custom Synthesis segment and decrease in covid product demand resulting in contraction of revenue and profits | Divi's Laboratories Q2 FY23 Result & Earning Call Highlights
Poor performance in the Custom Synthesis segment and decrease in covid product demand resulting in contraction of revenue and profits | Divi's Laboratories Q2 FY23 Result & Earning Call Highlights
Poor performance in the Custom Synthesis segment and decrease in covid product demand resulting in contraction of revenue and profits | Divi's Laboratories Q2 FY23 Result & Earning Call Highlights
Published on 11 November 2022 .Views 51.Comments 0
Download
